MASCC Society News - October 2020 Issue

Send your news item suggestions to [email protected]

Message from our President, Andrew Davies

Recently, the MASCC Board completed an exercise to update / develop our strategy for the next 2-4 years (i.e., the period of my presidency and of Dr Maryam Lustberg’s presidency). We will publish details of the strategy over the coming months, but some of the “headlines” are an increase in MASCC staffing (to support expanded activities), development of additional educational resources, and a revamping of the website format (in part to highlight existing / new educational resources).

MASCC is famous for its clinical guidelines, but these are not optimally showcased at the moment. The idea is to provide user-friendly, downloadable summaries of the guidelines for both members and non-members. Moreover, Dr Hannah Wardill is leading a pilot project looking at developing related patient-focussed information (which will also be downloadable from the website). We will be seeking volunteers for these projects in the near future (and would particularly like to hear from new / junior members).

In addition, we will be asking all of the study groups to identify novel topics for clinical guidelines, and to review whether their current guidelines are fit for purpose (i.e., up to date). Furthermore, we plan to develop a robust mechanism for reviewing / updating clinical guidelines (and “retiring” obsolete guidelines as needed). However, we also want to encourage other outputs from the study group, especially in areas where clinical guidelines are difficult to undertake. We also want to build on the success of recent webinars / other on-line activities.

Finally, we are continuing with preparations for the annual meeting in 2021 in Seville, Spain.  On the basis of feedback from the membership, and the second wave of COVID-19 in Europe (and the wider pandemic), we are preparing to hold a hybrid meeting, although there is a contingency to hold a purely virtual meeting. We will keep you up to date with developments, and hope to open new abstract submissions in the near future.

As always stay safe, and take care of yourself (and don’t forget to regularly stimulate your dopamine reward system).

- Andrew 

2020 Clinical Practice Recommendations for the Management of Immune-mediated Adverse Events from Checkpoint Inhibitors

MASCC presents a collection of 2020 clinical practice recommendations for the management of immune-mediated adverse events from checkpoint inhibitors. These recommendations are focused on patients with the most severe toxicities and provide an important international resource and reference in helping improve the management of these presentations.

Immune checkpoint inhibitors (ICIs) have emerged as the newest pillar of cancer treatment transforming outcomes in melanoma and showing benefit in a range of malignancies. ICIs include those targeting programmed death-1 and its ligand (PD-1 and PD-L1) and cytotoxic T lymphocyte antigen-4 (CTLA-4). Combinations of anti-PD-1/PD-L1 with anti-CTLA-4 augment immune responses and enhance clinical activity but increase the risk of toxicities.

Immune-mediated toxicities, stemming from increased activity within the T cell lineage, range from asymptomatic or mild complications to those that are fulminant and potentially fatal. They can affect virtually any organ system. Recognition and management of these toxicities is an important challenge in current Oncology care.

MASCC established the MASCC Subgroup on Immuno-Oncology (IO) in 2018 under the auspices of the Neutropenia, Infection, and Myelosuppression Study Group (SG). The IO subgroup comprises members from numerous medical specialties with an interest in IrAEs. Represented disciplines include, but are not limited to, gastroenterology, dermatology, neurology, immunology, hematology, rheumatology, endocrinology, nephrology, and emergency medicine.

MASCC appointed a multidisciplinary team of experts from different parts of the world including North America, South America, the UK, and South Africa and to develop these recommendations. In line with MASCC as a multidisciplinary professional association, the team was comprised of basic scientists and clinical investigators, including medical oncologists, emergency physicians, internal medicine sub-specialists, and specialist nurses.

Click here to read the entire collection link of recommendations, featured in a special edition in the journal of Supportive Care in Cancer.

Register Today for FREE Best of MASCC International Conference in Moscow on October 9

For the first time in Russia, the Russian Society of Supportive Care in Oncology (RASSC) and MASCC will hold the annual Best of MASCC International Conference on October 9 in Moscow (via online broadcast).

Russian and international experts in oncology, chemotherapy and radiotherapy, surgeons, dermatologists, therapists, cardiologists, palliative care specialists, nutritionists, nurses, psychologists, and psychotherapists will gather to discuss the problems of supportive care in the treatment of cancer patients.

The program includes:

  • Psychiatry and psychology in supportive care
  • Safety and efficacy of personalized therapy
  • Potential for maintaining the quality of life in patients with bone metastases
  • Modern antiemetic therapy in Russia and in the world
  • Nutritional support in oncology
  • Prevention of febrile neutropenia and treatment of infections
  • Surgical technologies in a complex system of supportive care
  • Issues of cardiotoxicity and hepatotoxicity
  • Prevention and treatment of anemia
  • Specifics of supportive care during the COVID-19 pandemic and a presentation of Russian doctors’ survey data.

Participation in the Best of MASCC is free. To register or for more information, click here.

2020 Sloan Kettering Management of Cancer Treatment-Related Adverse Events Symposium

The annual 2020 Sloan Kettering Management of Treatment-Related Adverse Events Symposium will be held from Friday, October 23 - Saturday, October 24. The course will be a virtual event this year instead of being held at its past location, Rockefeller Research Laboratories, New York, NY.

The course is directed by MASCC member Mario E. Lacouture, MD, who is the Director of the Oncodermatology Program at Memorial Sloan Kettering Cancer Center.

By registering for the live virtual course, participants will be able to view presentations, hear live audio, and interact online.

All sessions presented live on October 23-24, 2020 will be recorded and made available to attendees for viewing after the course. CME and ABIM MOC credit will be offered for this course and a certificate will be available after a post-course evaluation is complete.

Symposium Focus
Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, most patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies. Read more.

MASCC Announces Winner of Buddy Membership Program

Earlier this year, MASCC invited you to recruit and mentor one or more new MASCC members through a new initiative, the Buddy Membership Program. This program was designed to increase our membership and also to help new members get involved in MASCC activities and take advantage of all our membership benefits. The winner this year is Eduardo Fregnani, DDS, PhD – he recruited 124 new members!

Fregnani coordinates the Oral Medicine Service and is a permanent researcher at Sírio-Libanês Hospital in São Paulo, Brazil. Fregnani and all other buddy leaders agree to act as a mentor to their new member “buddies,” keeping in touch and helping the new member take advantage of MASCC’s resources and engage in MASCC’s Study Groups, activities, and events. Congratulations Eduardo!

Upcoming Conferences

Note: Rescheduling and cancellations occur frequently due to COVID-19. Please double check conference home pages for latest updates.

IASCC 2020 Annual Meeting
Mumbai, India

Best of MASCC International Conference
Moscow, Russia

October 16-18, 2020 – VIRTUAL CONFERENCE
17th International Conference on Integrative Oncology
The Science of Living Well with Cancer
This virtual conference theme this year is:
COVID-19 and Integrative Oncology: Meeting the Global Challenges of Health Equity

Baltimore, Maryland

October 23 – 24 – VIRTUAL CONFERENCE
2020 Sloan Kettering Management of Treatment-Related Adverse Events Symposium
New York, New York

November 18 – 19, 2020 - VIRTUAL CONFERENCE
ECCO - European Cancer Summit 2020: Working Together Against Cancer: Breaking Down Barriers & Saving Lives
Brussels, Belgium

November 19-21, 2020 - VIRTUAL CONFERENCE
UKONS Annual Conference
Nursing at the Core of Cancer Care

December 10 – 11 – VIRTUAL CONFERENCE
9th Annual Global Conference on Perioperative Care of the Cancer Patient
New York, NY

Annual Meeting Website

New MASCC Members

A warm welcome to the new members who joined us in September 2020!

Quy Lam (ISOO)

Antoine Lemaire
Antoine Smulevici
Catherine Duchastelle
Lea Loriguet
Magali Sebe

Richa Kundal
Sajeevan Kunivayalil

Alfredo Rossi (ISOO)
Katia Rupel

Daisuke Hirate
Fumio Nagashima
Hiroka Hohri
Kazuhiro Sumiyoshi
Kosuke Hamai
Masahito Takeuchi
Masaru Tsukui
Masato Masuda
Masayuki Takeda
Miho Suzuki
Takafumi  Miyoshi
Toshiyuki Ishiba
Yoshiyuki Kenmothu
Yuki Shimada

Rawabi AlRadhwan (ISOO)

Valérie Thiebaud

United Arab Emirates
Ramanujam Singarachari

United Kingdom
Alison Faulkner
Gillian Prue
Jane Hopkinson
Lesley Lloyd

United States
Andy Kurtzweil
Geetika Bhatt (ISOO)
Lisa Rootvik
Yoshie Sawin

Future Meetings
Mark your calendar and watch for more news about future MASCC/ISOO Annual Meetings!


Links to Notice


Supportive Care Positions & Fellowships
Employment opportunities, post-doctorate research fellowships and training programs.




Join MASCC's buzzing online community on
FacebookTwitter & LinkedIn 

The MASCC Society News is prepared by the MASCC Communications Manager Angela Perez and the MASCC Website Manager Beth Hollen. If you have any ideas for content or other comments about Society News, please email Angela Perez at [email protected].

All recent issues of the MASCC Society News are available online. Older issues (before 2013) can be found in the back pages of our journal, Supportive Care in Cancer.

This message has been sent to you because you are a MASCC member.
MASCC Privacy Notice  | Contact MASCC